← Open Payments lookup

ROBIN HOUSE: Open Payments

NPI 1003008095 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,938 in 128 payments from 14 companies in 2025. Trend: 2023 $1,525 · 2024 $5,405 · 2025 $1,938

Food & beverage: $1,938
CompanyPaymentsAmount
ABBVIE INC.34$473
Salix Pharmaceuticals, a division of Bausch Health US, LLC31$437
Madrigal Pharmaceuticals8$240
Aimmune Therapeutics, Inc.13$164
Ardelyx, Inc.11$151
Phathom Pharmaceuticals, Inc.12$99
Gilead Sciences, Inc.3$76
Novartis Pharmaceuticals Corporation4$67
GENZYME CORPORATION3$55
QOL Medical, LLC2$52

Products named: XIFAXAN, REZDIFFRA, MAVYRET, LINZESS, IBSRELA, ZENPEP, VOQUEZNA, LEQVIO.

Industry payments across KY — which companies pay providers there.